Biocryst Pharmaceuticals (BCRX)

Add to Watchlists
Create an Alert
10.00 -0.23  -2.25% NASDAQ Mar 6, 3:08PM BATS Real time Currency in USD
View Full Chart
BCRX Price Chart
View All Events

BCRX Events

Date Type Description
02/18/2015 11:00 EST Misc Biocryst Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2014
02/18/2015 Earnings Biocryst Pharmaceuticals Inc Fourth Quarter Earnings in 2014 Release
02/12/2015 08:55 EST Misc 2015 Leerink Global Healthcare Conference
11/06/2014 11:00 EST Misc Q3 2014 Biocryst Pharmaceuticals Earnings Call
11/06/2014 Earnings Q3 2014 Biocryst Pharmaceuticals Earnings Results
08/05/2014 11:00 EDT Misc Q2 2014 Biocryst Pharmaceuticals Earnings Call
08/05/2014 Earnings Q2 2014 Biocryst Pharmaceuticals Earnings Results
05/08/2014 Misc Q1 2014 Biocryst Pharmaceuticals Earnings Call
05/02/2014 15:00 EDT Misc Biocryst Announces Nature Publication Demonstrating Efficacy of Bcx4430 in a Non-human Primate Model of Filovirus Infection
05/02/2014 Misc Annual General Meeting for Biocryst Pharmaceuticals Inc
View All Performance Charts

BCRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biocryst Pharmaceuticals is down 22.06% over the last year vs S&P 500 Total Return up 12.86%, Chimerix up 106.5%, and Hemispherx Biopharma down 37.47%.

Get Quote for
Advertisement

Portfolio Strategies Featuring BCRX

Did Biocryst Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BCRX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.biocryst.com
  • IR Website: http://investor.shareholder.com/biocryst/index.cfm
  • HQ Country: United States
  • HQ State/Province: North Carolina
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: March 31, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Biocryst Pharmaceuticals Inc. is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include Peramivir, BCX4161, Forodesine and Ulodesine, among others.

BCRX Excel Add-In Codes

  • Name: =YCI("BCRX","name")
  • Description: =YCI("BCRX","description")
  • Sector: =YCI("BCRX","sector")
  • Industry: =YCI("BCRX","industry")
  • Est. Current Fiscal Year End: =YCI("BCRX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.